Literature DB >> 25943942

Early chronic obstructive pulmonary disease: definition, assessment, and prevention.

Stephen I Rennard1, M Bradley Drummond2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD, however, is a heterogeneous collection of diseases with differing causes, pathogenic mechanisms, and physiological effects. Therefore a comprehensive approach to COPD prevention will need to address the complexity of COPD. Advances in the understanding of the natural history of COPD and the development of strategies to assess COPD in its early stages make prevention a reasonable, if ambitious, goal.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25943942      PMCID： PMC4819246          DOI： 10.1016/S0140-6736(15)60647-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  101 in total

1.  A longitudinal study of the effects of parental smoking on pulmonary function in children 6-18 years.

Authors:  X Wang; D Wypij; D R Gold; F E Speizer; J H Ware; B G Ferris; D W Dockery
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

Review 2.  Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology.

Authors:  G L Snider
Journal:  Am Rev Respir Dis       Date:  1989-09

3.  Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).

Authors:  Benjamin M Smith; Eric A Hoffman; Dan Rabinowitz; Eugene Bleecker; Stephanie Christenson; David Couper; Kathleen M Donohue; Meilan K Han; Nadia N Hansel; Richard E Kanner; Eric Kleerup; Stephen Rennard; R Graham Barr
Journal:  Thorax       Date:  2014-06-13       Impact factor: 9.139

4.  Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS).

Authors:  Jennifer L Boes; Benjamin A Hoff; Maria Bule; Timothy D Johnson; Alnawaz Rehemtulla; Ryan Chamberlain; Eric A Hoffman; Ella A Kazerooni; Fernando J Martinez; Meilan K Han; Brian D Ross; Craig J Galbán
Journal:  Acad Radiol       Date:  2014-11-04       Impact factor: 3.173

5.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

6.  Complex chronic comorbidities of COPD.

Authors:  L M Fabbri; F Luppi; B Beghé; K F Rabe
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

7.  Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease?

Authors:  Roberto C Chin; Jordan A Guenette; Sicheng Cheng; Natya Raghavan; Naparat Amornputtisathaporn; Arturo Cortés-Télles; Katherine A Webb; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2013-06-15       Impact factor: 21.405

8.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease.

Authors:  D J Barker; K M Godfrey; C Fall; C Osmond; P D Winter; S O Shaheen
Journal:  BMJ       Date:  1991-09-21

Review 9.  Risk factors for the development of chronic obstructive pulmonary disease.

Authors:  E K Silverman; F E Speizer
Journal:  Med Clin North Am       Date:  1996-05       Impact factor: 5.456

10.  Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults.

Authors:  Roberto de Marco; Simone Accordini; Alessandro Marcon; Isa Cerveri; Josep M Antó; Thorarinn Gislason; Joachim Heinrich; Christer Janson; Deborah Jarvis; Nino Kuenzli; Bénédicte Leynaert; Jordi Sunyer; Cecilie Svanes; Matthias Wjst; Peter Burney
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405
View more
  59 in total

1.  A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.

Authors:  Elizabeth C Oelsner; Victor E Ortega; Benjamin M Smith; Jennifer N Nguyen; Ani W Manichaikul; Eric A Hoffman; Xiuqing Guo; Kent D Taylor; Prescott G Woodruff; David J Couper; Nadia N Hansel; Fernando J Martinez; Robert Paine; Meilan K Han; Christopher Cooper; Mark T Dransfield; Gerard Criner; Jerry A Krishnan; Russell Bowler; Eugene R Bleecker; Stephen Peters; Stephen S Rich; Deborah A Meyers; Jerome I Rotter; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

2.  Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.

Authors:  Yunus Çolak; Shoaib Afzal; Børge G Nordestgaard; Jørgen Vestbo; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

3.  Computerised respiratory sounds can differentiate smokers and non-smokers.

Authors:  Ana Oliveira; Ipek Sen; Yasemin P Kahya; Vera Afreixo; Alda Marques
Journal:  J Clin Monit Comput       Date:  2016-05-10       Impact factor: 2.502

4.  Back to the Future: Past, Present, and Future is COPD360.

Authors:  Michael W Hess; Barry Make
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-15

5.  Innate Immune Responses and Pulmonary Diseases.

Authors:  Tao Liu; Siqi Liu; Xiaobo Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; MeiLan K Han; James P Allinson; R Graham Barr; Richard C Boucher; Peter M A Calverley; Bartolome R Celli; Stephanie A Christenson; Ronald G Crystal; Malin Fagerås; Christine M Freeman; Lars Groenke; Eric A Hoffman; Mehmet Kesimer; Kostantinos Kostikas; Robert Paine; Shahin Rafii; Stephen I Rennard; Leopoldo N Segal; Renat Shaykhiev; Christopher Stevenson; Ruth Tal-Singer; Jørgen Vestbo; Prescott G Woodruff; Jeffrey L Curtis; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 7.  Initiating drug therapy in early stage chronic obstructive pulmonary disease: does it impact the course and outcome?

Authors:  Robert M Burkes; Michael B Drummond
Journal:  Curr Opin Pulm Med       Date:  2019-03       Impact factor: 3.155

8.  A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; David Mannino; Nancy Kline Leidy; Karen G Malley; Elizabeth D Bacci; R Graham Barr; Russ P Bowler; MeiLan K Han; Julia F Houfek; Barry Make; Catherine A Meldrum; Stephen Rennard; Byron Thomashow; John Walsh; Barbara P Yawn
Journal:  Am J Respir Crit Care Med       Date:  2017-03-15       Impact factor: 21.405

Review 9.  Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.

Authors:  Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic
Journal:  Respir Med       Date:  2019-08-09       Impact factor: 3.415

10.  A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria.

Authors:  Asli Gorek Dilektasli; Janos Porszasz; Richard Casaburi; William W Stringer; Surya P Bhatt; Youngju Pak; Harry B Rossiter; George Washko; Peter J Castaldi; Raul San Jose Estepar; James E Hansen
Journal:  Chest       Date:  2016-07-22       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.